Timothy P. Coughlin, Director at FATE THERAPEUTICS INC (FATE), bought 112,780 shares at $2.66 ($300K) on 2016-11-23, disclosed to the SEC on 2016-11-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.66 | 56,390 | $150K | 50.0% |
| 2 | $2.66 | 56,390 | $150K | 50.0% |
| Total | $2.66 avg | 112,780 | $300K | 100% |
| Filing → |
| NBIX | SELL | 2017-01-18 | $142K | — | Filing → |
| NBIX | SELL | 2017-01-12 | $152K | — | Filing → |
| NBIX | SELL | 2016-02-04 | $57K | — | Filing → |